Prevention of Hypertrophic Scars or Keloids

NCT ID: NCT00849004

Last Updated: 2012-10-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-03-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Keloids and hypertrophic scars are not major illness. However, their effects can be from causing pain and itch which substantially interfere daily activity to as severe as causing deformity and other functional impairment. For standard surgical wounds, taking median sternotomy wounds from open heart surgery and lower abdominal wounds from gynecological wounds for example, the incidence of these problems can be from 10% to 60%. To prevent or treat these problems, physicians have used many modalities. One of the most convenient, most cost-effective and most non-invasive methods for patients is using dressings like silicone sheets, silicone gels or paper tapes, which is on the list of 1st line choices of an international recommendation. According to a literature review, most of the previous studies on similar topics are either of small sample size, on non-standard wounds or comparisons between wounds on different patient groups. The methodologies of previous studies are thus not vigorous enough. To get the highest level of evidence on selecting the best dressings for preventing and treating keloids and hypertrophic scars, we will recruit about 75 patients and apply two selected dressings on each halves of their standard surgical wounds to compare their differences. The investigators hope the result of this study can help us find the best modality to use and can contribute to the welfare of our future patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients who undergo gynecological surgery with transverse lower abdominal wounds and who undergo cardiovascular surgery with median sternotomy wounds in our hospital will be assessed. Those who have or will have diabetes, chemotherapy, radiotherapy and known history of allergy to silicone will be excluded. Altogether, about 75 patients will be recruited. Each patient's wound will be divided into two halves. One test dressing will be applied to a half, which is determined by random, and a different test dressing to the other half. The total 75 patients will thus be divided into 3 groups of 25 patients. One group will act to compare the effectiveness between silicone gel and silicone sheet, the second group between silicone sheet and paper tape, and the third group between silicone gel and paper tape. The dressings will be applied one week after surgery and at least 12 hours per day until 3 months after surgery. All patients will be followed up at 4 weeks, 8 weeks, 12 weeks, 6 months and 12 months. Three domains of outcomes will be measured. One is the appearance of the scars which will be rated with Vancouver scale, which has been proved to be a reliable scale.34 35 When rating with the Vancouver scale, standardised photographs of the scars will be taken in a standardised photo studio using a single high-resolution digital camera in a standardised light condition and at a fixed distance because any difference in photographic conditions will make difference in the Vancouver scores. The other two domains are pain and itching of the scars, which will be evaluated with Visual Analog Ratings (VAR). Pain and itching are very subjective, so the rating method should be very easy to understand and applicable for our patients and that is why we chose VAR as a tool.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertrophic Scars

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

keloid silicone sheet silicone gel paper tape steri-strip

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gel vs. Sheet

One group will act to compare the effectiveness between silicone gel and silicone sheet.

Group Type ACTIVE_COMPARATOR

silicone gel

Intervention Type OTHER

silicone gel

silicone sheet

Intervention Type OTHER

silicone sheet

sheet vs. paper tape

The second group between silicone sheet and paper tape.

Group Type ACTIVE_COMPARATOR

silicone sheet

Intervention Type OTHER

silicone sheet

paper tape

Intervention Type OTHER

paper tape

gel vs. paper tape

One group will act to compare the effectiveness between silicone gel and paper tape.

Group Type ACTIVE_COMPARATOR

silicone gel

Intervention Type OTHER

silicone gel

paper tape

Intervention Type OTHER

paper tape

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

silicone gel

silicone gel

Intervention Type OTHER

silicone sheet

silicone sheet

Intervention Type OTHER

paper tape

paper tape

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who undergo gynecological surgery with transverse lower abdominal wounds.
* Patients who undergo cardiovascular surgery with median sternotomy wounds in our hospital will be assessed.

Exclusion Criteria

* Those who have or will have:

* diabetes
* chemotherapy
* radiotherapy
* known history of allergy to silicone will be excluded.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaohsiung Veterans General Hospital.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kuei-Chang Hsu

Consultant Surgeon

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kuei-Chang Hsu, surgeon

Role: PRINCIPAL_INVESTIGATOR

Department of plastic surgery in Kaohsiung Veterans General Hospital in Taiwan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kaohsiung Veterans General Hospital: R.O.C.

Kaohsiung City, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

References

Explore related publications, articles, or registry entries linked to this study.

Pellard S. Epidemiology, aetiology and management of abnormal scarring: a review of the literature. J Wound Care. 2006 Jan;15(1):44-8. doi: 10.12968/jowc.2006.15.1.26863.

Reference Type BACKGROUND
PMID: 16669306 (View on PubMed)

Murison M, James W. Preliminary evaluation of the efficacy of dermatix silicone gel in the reduction of scar elevation and pigmentation. J Plast Reconstr Aesthet Surg. 2006;59(4):437-9. doi: 10.1016/j.bjps.2005.09.037. No abstract available.

Reference Type BACKGROUND
PMID: 16756266 (View on PubMed)

Rayner K. The use of pressure therapy to treat hypertrophic scarring. J Wound Care. 2000 Mar;9(3):151-3. No abstract available.

Reference Type BACKGROUND
PMID: 11933297 (View on PubMed)

Mustoe TA. Scars and keloids. BMJ. 2004 Jun 5;328(7452):1329-30. doi: 10.1136/bmj.328.7452.1329. No abstract available.

Reference Type BACKGROUND
PMID: 15178589 (View on PubMed)

Baryza MJ, Baryza GA. The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil. 1995 Sep-Oct;16(5):535-8. doi: 10.1097/00004630-199509000-00013.

Reference Type BACKGROUND
PMID: 8537427 (View on PubMed)

Wu WS, Wang FS, Yang KD, Huang CC, Kuo YR. Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol. 2006 Jun;126(6):1264-71. doi: 10.1038/sj.jid.5700274.

Reference Type RESULT
PMID: 16575391 (View on PubMed)

Giovannini UM. Treatment of scars by steroid injections. Wound Repair Regen. 2002 Mar-Apr;10(2):116-7. doi: 10.1046/j.1524-475x.2002.00206.x. No abstract available.

Reference Type RESULT
PMID: 12028527 (View on PubMed)

Chuangsuwanich A, Osathalert V, Muangsombut S. Self-adhesive silicone gel sheet: a treatment for hypertrophic scars and keloids. J Med Assoc Thai. 2000 Apr;83(4):439-44.

Reference Type RESULT
PMID: 10808705 (View on PubMed)

Suetak T, Sasai S, Zhen YX, Tagami H. Effects of silicone gel sheet on the stratum corneum hydration. Br J Plast Surg. 2000 Sep;53(6):503-7. doi: 10.1054/bjps.2000.3388.

Reference Type RESULT
PMID: 10927682 (View on PubMed)

Borgognoni L. Biological effects of silicone gel sheeting. Wound Repair Regen. 2002 Mar-Apr;10(2):118-21. doi: 10.1046/j.1524-475x.2002.00205.x. No abstract available.

Reference Type RESULT
PMID: 12028528 (View on PubMed)

Musgrave MA, Umraw N, Fish JS, Gomez M, Cartotto RC. The effect of silicone gel sheets on perfusion of hypertrophic burn scars. J Burn Care Rehabil. 2002 May-Jun;23(3):208-14. doi: 10.1097/00004630-200205000-00010.

Reference Type RESULT
PMID: 12032371 (View on PubMed)

Quinn KJ. Silicone gel in scar treatment. Burns Incl Therm Inj. 1987 Oct;13 Suppl:S33-40. doi: 10.1016/0305-4179(87)90091-x. No abstract available.

Reference Type RESULT
PMID: 3690373 (View on PubMed)

Ahn ST, Monafo WW, Mustoe TA. Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch Surg. 1991 Apr;126(4):499-504. doi: 10.1001/archsurg.1991.01410280103016.

Reference Type RESULT
PMID: 2009067 (View on PubMed)

Katz BE. Silicone gel sheeting in scar therapy. Cutis. 1995 Jul;56(1):65-7.

Reference Type RESULT
PMID: 7555106 (View on PubMed)

Niessen FB, Spauwen PH, Robinson PH, Fidler V, Kon M. The use of silicone occlusive sheeting (Sil-K) and silicone occlusive gel (Epiderm) in the prevention of hypertrophic scar formation. Plast Reconstr Surg. 1998 Nov;102(6):1962-72. doi: 10.1097/00006534-199811000-00023.

Reference Type RESULT
PMID: 9810992 (View on PubMed)

Chan KY, Lau CL, Adeeb SM, Somasundaram S, Nasir-Zahari M. A randomized, placebo-controlled, double-blind, prospective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound. Plast Reconstr Surg. 2005 Sep 15;116(4):1013-20; discussion 1021-2. doi: 10.1097/01.prs.0000178397.05852.ce.

Reference Type RESULT
PMID: 16163087 (View on PubMed)

Atkinson JA, McKenna KT, Barnett AG, McGrath DJ, Rudd M. A randomized, controlled trial to determine the efficacy of paper tape in preventing hypertrophic scar formation in surgical incisions that traverse Langer's skin tension lines. Plast Reconstr Surg. 2005 Nov;116(6):1648-56; discussion 1657-8. doi: 10.1097/01.prs.0000187147.73963.a5.

Reference Type RESULT
PMID: 16267427 (View on PubMed)

Abergel RP, Dwyer RM, Meeker CA, Lask G, Kelly AP, Uitto J. Laser treatment of keloids: a clinical trial and an in vitro study with Nd:YAG laser. Lasers Surg Med. 1984;4(3):291-5. doi: 10.1002/lsm.1900040310.

Reference Type RESULT
PMID: 6390045 (View on PubMed)

Bouzari N, Davis SC, Nouri K. Laser treatment of keloids and hypertrophic scars. Int J Dermatol. 2007 Jan;46(1):80-8. doi: 10.1111/j.1365-4632.2007.03104.x.

Reference Type RESULT
PMID: 17214728 (View on PubMed)

Chan HH, Wong DS, Ho WS, Lam LK, Wei W. The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in chinese persons. Dermatol Surg. 2004 Jul;30(7):987-94; discussion 994. doi: 10.1111/j.1524-4725.2004.30303.x.

Reference Type RESULT
PMID: 15209788 (View on PubMed)

McCraw JB, McCraw JA, McMellin A, Bettencourt N. Prevention of unfavorable scars using early pulse dye laser treatments: a preliminary report. Ann Plast Surg. 1999 Jan;42(1):7-14. doi: 10.1097/00000637-199901000-00002.

Reference Type RESULT
PMID: 9972711 (View on PubMed)

Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther. 2004;17(2):212-8. doi: 10.1111/j.1396-0296.2004.04022.x.

Reference Type RESULT
PMID: 15113289 (View on PubMed)

Staley MJ, Richard RL. Use of pressure to treat hypertrophic burn scars. Adv Wound Care. 1997 May-Jun;10(3):44-6.

Reference Type RESULT
PMID: 9306778 (View on PubMed)

Macintyre L, Baird M. Pressure garments for use in the treatment of hypertrophic scars--a review of the problems associated with their use. Burns. 2006 Feb;32(1):10-5. doi: 10.1016/j.burns.2004.06.018.

Reference Type RESULT
PMID: 16413399 (View on PubMed)

Puzey G. The use of pressure garments on hypertrophic scars. J Tissue Viability. 2002 Jan;12(1):11-5. doi: 10.1016/s0965-206x(02)80004-3.

Reference Type RESULT
PMID: 11887386 (View on PubMed)

Ng CL, Lee ST, Wong KL. Pressure garments in the prevention and treatment of keloids. Ann Acad Med Singap. 1983 Apr;12(2 Suppl):430-5.

Reference Type RESULT
PMID: 6625526 (View on PubMed)

Kal HB, Veen RE. Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship. Strahlenther Onkol. 2005 Nov;181(11):717-23. doi: 10.1007/s00066-005-1407-6.

Reference Type RESULT
PMID: 16254707 (View on PubMed)

Narkwong L, Thirakhupt P. Postoperative radiotherapy with high dose rate iridium 192 mould for prevention of earlobe keloids. J Med Assoc Thai. 2006 Apr;89(4):428-33.

Reference Type RESULT
PMID: 16696385 (View on PubMed)

Gusak VK, Fistal' EIa, Speranskii II, Zagoruiko NN. [Cryotherapy of postburn hypertrophic scars]. Klin Khir (1962). 1994;(1-2):15-7. Russian.

Reference Type RESULT
PMID: 8078236 (View on PubMed)

Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg. 2003 May;111(6):1841-52. doi: 10.1097/01.PRS.0000056868.42679.05.

Reference Type RESULT
PMID: 12711943 (View on PubMed)

O'Brien L, Pandit A. Silicon gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003826. doi: 10.1002/14651858.CD003826.pub2.

Reference Type RESULT
PMID: 16437463 (View on PubMed)

Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am. 1997 Jun;77(3):701-30. doi: 10.1016/s0039-6109(05)70576-4.

Reference Type RESULT
PMID: 9194888 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

97CT1018

Identifier Type: -

Identifier Source: secondary_id

97CT1018

Identifier Type: -

Identifier Source: org_study_id